Thyroidectomy without Radioiodine in Low- Risk Thyroid Cancer Reply

被引：0
作者：
Leboulleux, Sophie [1 ]
Schlumberger, Martin-Jean [2 ]
Borget, Isabelle [2 ]
机构：
[1] Hop Univ Geneve, Geneva, Switzerland
[2] Gustave Roussy, Villejuif, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 22期
关键词：
ABLATION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2155 / 2155
页数：1
相关论文
共 50 条
  • [41] The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
    Taprogge, Jan
    Abreu, Carla
    Yusuf, Siraj
    Ainsworth, Gemma
    Phillip, Rachel H.
    Gear, Jonathan I.
    Gregory, Rebecca
    Leek, Francesca
    Murray, Iain
    Coulson, Amy B.
    Brown, Sarah R.
    Du, Yong
    Newbold, Kate
    Wadsley, Jonathan
    Flux, Glenn D.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (07) : 1125 - 1130
  • [42] Comparison of models predicting efficacy of radioiodine therapy in patients with differentiated thyroid cancer
    Borowczyk, Martyna
    Jodlowska-Siewert, Elzbieta
    Filipowicz, Dorota
    Komarnicki, Pawel
    Verburg, Frederik A.
    Ziemnicka, Katarzyna
    Szczepanek-Parulska, Ewelina
    Ruchala, Marek
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2025,
  • [43] Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation
    Musso, Laura
    Maltese, Cristina
    Beretta, Giulio
    Patelli, Ilaria
    Raffa, Stefano
    Piccardo, Arnoldo
    Fiz, Francesco
    Vera, Lara
    Albertelli, Manuela
    Minuto, Michele
    Ferone, Diego
    Bagnasco, Marcello
    Gay, Stefano
    PHARMACEUTICALS, 2025, 18 (04)
  • [44] Value of follow-up diagnostic radioiodine scans in differentiated thyroid cancer
    Kraus, Teresa
    Shengelia-de Lange, Natalia
    Einspieler, Holger
    Hacker, Marcus
    Haug, Alexander
    Kretschmer-Chott, Elisabeth
    Karanikas, Georgios
    ENDOCRINE CONNECTIONS, 2024, 13 (05)
  • [45] Absorbed dose coefficients for adult thyroid cancer patients undergoing radioiodine therapy
    Kwon, Tae-Eun
    Pasqual, Elisa
    Kitahara, Cari M.
    Lee, Choonsik
    JOURNAL OF RADIOLOGICAL PROTECTION, 2023, 43 (02)
  • [46] Targeted therapy in patients with radioiodine-refractory differentiated thyroid cancer (DTC)
    Herceg, Davorin
    Herceg, Gordana Horvatic
    PERIODICUM BIOLOGORUM, 2014, 116 (04) : 399 - 407
  • [47] Added Value of Postoperative Radioiodine Scan for Staging and Risk Stratification in Papillary Thyroid Microcarcinoma
    Kaewchur, Tawika
    Namwongprom, Sirianong
    Waisayanand, Nipawan
    Pongwiwattanachai, Waralee
    Ekmahachai, Molrudee
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2021, 36 (01): : 64 - 68
  • [48] Clinicopathological relevance of antithyroglobulin antibodies in low-risk papillary thyroid cancer
    Morand, G. B.
    da Silva, S. D.
    Mlynarek, A. M.
    Black, M. J.
    Payne, R. J.
    Hier, M. P.
    CLINICAL OTOLARYNGOLOGY, 2017, 42 (06) : 1130 - 1134
  • [49] Postoperative thyroid remnants for differentiated thyroid cancer may not affect the outcome of high-dose radioiodine therapy
    Pan, Liqin
    Chen, Yanying
    Li, Sixiao
    Ouyang, Wei
    Feng, Huijuan
    Wu, Juqing
    Chen, Pan
    Deng, Yuying
    Wang, Jing
    Luo, Jiaxin
    Xian, Jialan
    ORAL ONCOLOGY, 2020, 104
  • [50] Postoperative Unstimulated Thyroglobulin for the Decision to Use Radioactive Iodine in Patients with Low- or Intermediate-Risk Papillary Thyroid Carcinoma
    Rosario, Pedro Weslley
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (Suppl 3) : S867 - S868
12345